ArticleBreast cancer (Tokyo, Japan)2026

Pathologic complete response and survival according to germline BRCA1/2 status in triple-negative breast cancer.

Paulina Gebhart et al.PubMed ↗Publisher ↗

No numbers read from the abstract.